Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
出版年份 2019 全文链接
标题
Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
作者
关键词
Flubendazole, Colorectal cancer, STAT3, Autophagy, Apoptosis
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-08
DOI
10.1186/s13046-019-1303-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
- (2019) Lehe Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
- (2019) Jia Wei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer
- (2019) Shengling Fu et al. CANCER LETTERS
- Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society
- (2018) Andrew M. D. Wolf et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer
- (2018) Yoon-Jae Kim et al. CANCER LETTERS
- Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2018) Eunhye Oh et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide
- (2018) Lu Lu et al. ONCOGENE
- Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
- (2018) Jenny D. Beebe et al. PHARMACOLOGY & THERAPEUTICS
- Drug Repurposing Screening Identifies Tioconazole as an ATG4 Inhibitor that Suppresses Autophagy and Sensitizes Cancer Cells to Chemotherapy
- (2018) Pei-Feng Liu et al. Theranostics
- AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer
- (2018) Hong ZHU et al. Theranostics
- Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling
- (2018) Hailun Zheng et al. MOLECULAR CARCINOGENESIS
- Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
- (2018) Ioanna Keklikoglou et al. NATURE CELL BIOLOGY
- Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
- (2018) Ning Wei et al. ONCOGENE
- Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
- (2017) T Zhang et al. ONCOGENE
- STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
- (2017) Wei-Ying Kuo et al. Theranostics
- Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
- (2016) Chengguang Zhao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The role of STAT3 in autophagy
- (2015) Liangkun You et al. Autophagy
- Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential
- (2015) Santosh Chauhan et al. Nature Communications
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now